Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 214 (TMEM214) is a human protein localized primarily to the outer membrane of the endoplasmic reticulum, where it functions as a critical mediator of ER stress-induced apoptosis. TMEM214 achieves this role through a constitutive association and anchoring of procaspase 4, which is then activated during cellular stress resulting in apoptosis. Overexpression of TMEM214 induces apoptosis, while knockdown inhibits ER stress-induced apoptosis, confirming its essential role in cell death triggered by accumulation of misfolded proteins and ER stress. TMEM214 contains two transmembrane domains at its C-terminal region and a cytoplasmic N-terminal region important for its interaction with procaspase 4. While it is implicated in muscle diseases and may play a role in cellular responses related to cancer and tissue homeostasis, there are no established drugs, mechanisms, or biomarkers directly targeting TMEM214 clinically, nor are there reported safety concerns in therapeutic contexts.
Anchoring procaspase 4 to the ER outer membrane. Facilitating caspase 4 activation in response to ER stress.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 214 (TMEM214).